Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / June / Combination Therapy Targets Bacterial Keratitis
Health Economics and Policy Refractive News

Combination Therapy Targets Bacterial Keratitis

Study examines antimicrobial and anti-inflammatory benefits of combined levofloxacin and ibuprofen for Staphylococcus aureus-induced keratitis

6/4/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
  • Topic Commentary
4 Topic Commentaries

Combination Therapy Targets Bacterial Keratitis

Combination Therapy Targets Bacterial Keratitis

  • Nisha R. Acharya
    Nisha R. Acharya, MD, MS

    Ophthalmology (Uveitis/Cornea)

    •

    University of California, San Francisco (UCSF) Department of Ophthalmology

    “We consider this finding very significant; it’s a clinically meaningful difference,” said the paper’s co-author Nisha Acharya, MD, MS, associate professor and director of the Uveitis Service in the UCSF Department of Ophthalmology. Although secondary to the study’s original purpose, Acharya said the results in severe cases were identified early on, so “we didn’t start doing all of these analyses after the fact. It was of interest. So I think there is something there.”

    Source
  • Nisha R. Acharya
    Nisha R. Acharya, MD, MS

    Ophthalmology (Uveitis/Cornea)

    •

    University of California, San Francisco (UCSF) Department of Ophthalmology

    “It’s important to note that in the worst ulcer group, not only do we not find a safety problem, we actually found that steroids resulted in a benefit in vision,” Acharya said. “So I think that is really reassuring because those were the people with whom we were most scared to use steroids.”

    Source
  • Nisha R. Acharya
    Nisha R. Acharya, MD, MS

    Ophthalmology (Uveitis/Cornea)

    •

    University of California, San Francisco (UCSF) Department of Ophthalmology

    “There was no increase in cornea perforations in our patient population,” Acharya said. “I’m reassured to know that it’s not associated with harm.”

    Source
  • Nisha R. Acharya
    Nisha R. Acharya, MD, MS

    Ophthalmology (Uveitis/Cornea)

    •

    University of California, San Francisco (UCSF) Department of Ophthalmology

    “It makes us feel like we’re moving towards an evidence-based paradigm of care for corneal ulcers rather than a trial and error sort of approach,” Acharya said. “We have a good collaboration and now that we’ve had some success with this, we hope to be able to continue with it to answer other questions related to this field.”

    Source

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: